GSK Signs Deal For Tolerx Anti-CD3 Antibody For Type 1 Diabetes
This article was originally published in The Pink Sheet Daily
Executive Summary
Tolerx plans to file BLA for humanized anti-CD3 monoclonal antibody in type 1 diabetes in late 2010, CEO tells “The Pink Sheet” DAILY.